TR199701541T1 - Proteinaz engelleyici ve tekli gliserid içeren farmasötik bilesim. - Google Patents

Proteinaz engelleyici ve tekli gliserid içeren farmasötik bilesim.

Info

Publication number
TR199701541T1
TR199701541T1 TR97/01541T TR9701541T TR199701541T1 TR 199701541 T1 TR199701541 T1 TR 199701541T1 TR 97/01541 T TR97/01541 T TR 97/01541T TR 9701541 T TR9701541 T TR 9701541T TR 199701541 T1 TR199701541 T1 TR 199701541T1
Authority
TR
Turkey
Prior art keywords
monoglyceride
pharmaceutical composition
composition containing
proteinase inhibitor
containing proteinase
Prior art date
Application number
TR97/01541T
Other languages
English (en)
Inventor
Anne Bailey Carole
Josephine Ferdinando Christine
Shah Navnit
Original Assignee
F.Hoffmann-La Roche Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/616,233 external-priority patent/US6008228A/en
Application filed by F.Hoffmann-La Roche Ag filed Critical F.Hoffmann-La Roche Ag
Publication of TR199701541T1 publication Critical patent/TR199701541T1/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/472—Non-condensed isoquinolines, e.g. papaverine
    • A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

Proteinaz engelleyicilerin biyolojik mevcudiyetini arttiran bilesimler açiga çikartilmistir. Bilesimlere orta boy yag-zincir asitli tekli gliseridlerden olusan farmasötik kabul edilen tasiyicilar dahil edilmistir.
TR97/01541T 1995-06-06 1996-06-04 Proteinaz engelleyici ve tekli gliserid içeren farmasötik bilesim. TR199701541T1 (tr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US46849395A 1995-06-06 1995-06-06
US08/616,233 US6008228A (en) 1995-06-06 1996-05-07 Pharmaceutical compositions containing proteinase inhibitors

Publications (1)

Publication Number Publication Date
TR199701541T1 true TR199701541T1 (tr) 1998-03-21

Family

ID=27042422

Family Applications (1)

Application Number Title Priority Date Filing Date
TR97/01541T TR199701541T1 (tr) 1995-06-06 1996-06-04 Proteinaz engelleyici ve tekli gliserid içeren farmasötik bilesim.

Country Status (27)

Country Link
EP (1) EP0831826B1 (tr)
JP (1) JP3238412B2 (tr)
CN (1) CN1092960C (tr)
AT (1) ATE226075T1 (tr)
AU (1) AU709796B2 (tr)
BG (1) BG63711B1 (tr)
BR (1) BR9610842A (tr)
CA (1) CA2224125C (tr)
CY (1) CY2373B1 (tr)
CZ (1) CZ292192B6 (tr)
DE (1) DE69624354T2 (tr)
DK (1) DK0831826T3 (tr)
EA (1) EA001413B1 (tr)
ES (1) ES2182996T3 (tr)
HK (1) HK1010136A1 (tr)
HU (1) HU223899B1 (tr)
IL (1) IL122353A0 (tr)
IS (1) IS2661B (tr)
MX (1) MX9709193A (tr)
NO (1) NO324531B1 (tr)
NZ (1) NZ311646A (tr)
OA (1) OA10546A (tr)
PL (1) PL184820B1 (tr)
PT (1) PT831826E (tr)
SK (1) SK282121B6 (tr)
TR (1) TR199701541T1 (tr)
WO (1) WO1996039142A1 (tr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE225174T1 (de) 1997-07-29 2002-10-15 Upjohn Co Selbstemulgierende formulierung enthaltend saure lipophile verbindungen
DE69804624T2 (de) 1997-07-29 2002-09-19 Upjohn Co Selbstemulgierende formulierung enthaltend lipophile verbindungen
NZ513441A (en) * 1999-02-08 2004-01-30 Alza Corp Stable non-aqueous single phase viscous drug delivery vehicles comprising a polymer a solvent and a surfactant
US7919109B2 (en) 1999-02-08 2011-04-05 Intarcia Therapeutics, Inc. Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles
US7258869B1 (en) 1999-02-08 2007-08-21 Alza Corporation Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicle
US6956048B2 (en) 1999-03-31 2005-10-18 Pharmacia & Upjohn Company Pharmaceutical emulsions for retroviral protease inhibitors
US6309663B1 (en) * 1999-08-17 2001-10-30 Lipocine Inc. Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents
BR0202252A (pt) 2002-06-12 2004-06-29 Cristalia Prod Quimicos Farm Composição farmacêutica solúvel estável para administração de inibidores da hiv protease e processo de obtenção de composições farmacêuticas concentradas para a administração de inibidores da hiv protease
US7731947B2 (en) 2003-11-17 2010-06-08 Intarcia Therapeutics, Inc. Composition and dosage form comprising an interferon particle formulation and suspending vehicle
WO2006083761A2 (en) 2005-02-03 2006-08-10 Alza Corporation Solvent/polymer solutions as suspension vehicles
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
ES2351527T3 (es) 2006-05-30 2011-02-07 Intarcia Therapeutics, Inc Modulador de flujo en dos piezas con conducto interno para un sistema osmótico de administración.
EP2157967B1 (en) 2007-04-23 2013-01-16 Intarcia Therapeutics, Inc Suspension formulations of insulinotropic peptides and uses thereof
WO2009102467A2 (en) 2008-02-13 2009-08-20 Intarcia Therapeutics, Inc. Devices, formulations, and methods for delivery of multiple beneficial agents
EP2108705A1 (en) 2008-04-08 2009-10-14 Universität Duisburg-Essen Method for analysing the epigenetic status of the HtrA 1 gene in a biological sample
LT2462246T (lt) 2009-09-28 2017-11-27 Intarcia Therapeutics, Inc Esminio stacionaraus vaisto tiekimo greitas įgyvendinimas ir (arba) nutraukimas
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
JP6993235B2 (ja) 2015-06-03 2022-01-13 インターシア セラピューティクス，インコーポレイティド インプラントの設置及び撤去システム
EP3458084B1 (en) 2016-05-16 2020-04-01 Intarcia Therapeutics, Inc Glucagon-receptor selective polypeptides and methods of use thereof
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
KR20190104039A (ko) 2017-01-03 2019-09-05 인타르시아 세라퓨틱스 인코포레이티드 Glp-1 수용체 효능제의 연속적인 투여 및 약물의 동시-투여를 포함하는 방법

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8927913D0 (en) * 1989-12-11 1990-02-14 Hoffmann La Roche Amino acid derivatives
IL110752A (en) * 1993-09-13 2000-07-26 Abbott Lab Liquid semi-solid or solid pharmaceutical composition for an HIV protease inhibitor

Also Published As

Publication number Publication date
BG102106A (en) 1998-08-31
AU709796B2 (en) 1999-09-09
DE69624354T2 (de) 2003-06-05
PL184820B1 (pl) 2002-12-31
ES2182996T3 (es) 2003-03-16
WO1996039142A1 (en) 1996-12-12
EP0831826B1 (en) 2002-10-16
CN1092960C (zh) 2002-10-23
EA001413B1 (ru) 2001-02-26
NO975665L (no) 1998-02-05
HUP9801905A3 (en) 2001-04-28
NO975665D0 (no) 1997-12-05
EA199800023A1 (ru) 1998-08-27
CA2224125C (en) 2004-09-28
MX9709193A (es) 1998-03-31
AU6300496A (en) 1996-12-24
NO324531B1 (no) 2007-11-12
IL122353A0 (en) 1998-04-05
NZ311646A (en) 2000-02-28
ATE226075T1 (de) 2002-11-15
JP3238412B2 (ja) 2001-12-17
CZ380397A3 (cs) 1998-03-18
HK1010136A1 (en) 1999-06-17
CZ292192B6 (cs) 2003-08-13
IS2661B (is) 2010-08-15
CA2224125A1 (en) 1996-12-12
JPH10507202A (ja) 1998-07-14
PL323860A1 (en) 1998-04-27
BG63711B1 (bg) 2002-10-31
EP0831826A1 (en) 1998-04-01
CN1186434A (zh) 1998-07-01
CY2373B1 (en) 2004-06-04
PT831826E (pt) 2003-02-28
HUP9801905A2 (hu) 1999-05-28
DK0831826T3 (da) 2003-02-03
SK162797A3 (en) 1998-05-06
HU223899B1 (hu) 2005-03-29
DE69624354D1 (de) 2002-11-21
OA10546A (en) 2002-05-29
BR9610842A (pt) 1999-07-13
SK282121B6 (sk) 2001-11-06
IS4627A (is) 1997-12-04

Similar Documents

Publication Publication Date Title
TR199701541T1 (tr) Proteinaz engelleyici ve tekli gliserid içeren farmasötik bilesim.
BG103425A (en) Pharmaceutical composition
IS2180B (is) Lyfjasamsetning sem inniheldur eikósapentaensýru og/eða steridónsýru
BG104779A (en) Inhibitors of phospholipase enzymes
ATE278397T1 (de) Verwendung von cytoskelettinhibitoren zur vorbeugung der restenose
CA2305394A1 (en) Local administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction
TR199801151T2 (tr) Trombin inhibitörü ön ilaçlar.
DE69326149D1 (de) (3R,4R)--g(D)?6-TETRAHYDROCANNABINOL-7-CARBONSÄUREN
WO1999005096A3 (en) Urokinase inhibitors
ATE285783T1 (de) Feste lipidformulierung enthaltend lipasehemmer und fettsäureester von polyolen
MY116525A (en) Pharmaceutical composition comprising a proteinase inhibitor and a monoglyceride
DK0512071T3 (da) Fremgangsmåde og sammensætninger til inhibering af angiogenese
AU7239996A (en) Inhibition of tumor necrosis factor alpha
CA2004332A1 (en) Inhibition of cell adhesion
IT1276162B1 (it) Geranilgeranil-derivati,procedimento per la loro preparazione e relative composizioni farmaceutiche
TR199501429A2 (tr) Matriks metaloproteaz inhibitörlerinin yerine gecen 4-biarilpentanoik asitleri ve türevleri
EP0796262A4 (en) 7-ALKYLIDENE CEPHALOSPORANIC ACID DERIVATIVES AND METHODS OF USE THEREOF
IT8021671A0 (it) Esteri idrosolubili di steroido-ossazoli e loro composizioni farmaceutiche.
WO2004055154A3 (en) Use of purine derivatives for inducing differentiation of supernumerary hair cells and deiters' cells in the developing organ of corti for treating deafness
EP0993468A4 (en) PREPARATIONS AND METHOD FOR ACTIVATING CERTAIN GENES
ITRM930073A0 (it) Metodo di propagazione in vitro di cellule til.
ECSP961778A (es) Composiciones que incrementan la biodisponibilidad de inhibidores de proteinasa
IT1255242B (it) Composizioni farmaceutiche atte al trattamento dei disturbi della memoria.
TNSN00242A1 (en) VALDECOXIB COMPOSITIONS